Efficacy and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer With Lymph Node Metastasis
In previously treated patients with unresectable NSCLC and lymph node metastasis, real-world evidence from this study suggests that pembrolizumab monotherapy offers superior efficacy and survival benefits compared with docetaxel chemotherapy. Moreover, the two therapies display distinct safety profiles, with ICI therapy associated with fewer severe hematologic toxicities.
Authors
- Liangliang Xue
- Kai Ma (ORCID: https://orcid.org/0000-0001-7535-1313)
- Ge Wang
- Ru Ma
- Wenhai Li
Institutions
- Medical Center Hospital (US)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- British Journal of Hospital Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.31083/bjhm50722
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00